The South African Health Products Regulatory Authority says there are no major safety concerns with the Johnson and Johnson vaccine.
It has studied the data from the Sisonke trial and found no reports of blood clots.
The body is now recommending lifting the suspension on the Sisonke study but says there should be better screening and monitoring of participants at high risk of blood clotting disorders.
The regulator also says all participants should be informed about the risk of developing the disorder.
South Africa suspended the trial after US Federal Health Agencies recommended the pause.
Six women there developed a blood clotting disorder after receiving the Johnson & Johnson vaccine.
More Stories
SA Won’t Go Beyond Stage 6 Power Cuts – Ramokgopa
World TB Day – Yes! We Can End TB
Medical Fees Rise By 5.3% In February – Stats SA
Power Cuts Case Continues
Ramokgopa Tours Troubled Tutuka
EFF’s No-Confidence Motion Against Speaker Fails
The National Treasury Should Do More To Alleviate Household Costs Of Loadshedding
Eskom Concedes That Outrage Over Power Cuts Warranted
Electricity Minister To Visit All Power Stations
Over 500 Arrested Nationwide During Protest Action
Malema Rubbishes Concerns That EFF Nationwide Protest Will Turn Violent
Santaco Says Taxi Industry Will Operate As Normal